{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:18:25Z","timestamp":1793449105708,"version":"4.5.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatoblastoma is the most common primary liver tumor in children, accounting for just over 1% of pediatric cancers. The etiology is unknown, but it has been associated with Beckwith-Weidemann syndrome, familial adenomatosis polypi, and low birth weight. The primary treatment is surgical resection, however, chemotherapy plays an important role by increasing the number of tumors that are resectable. The prognosis for patients with resectable tumors is fairly good, however, the outcome for those with nonresectable or recurrent disease is poor.<\/jats:p>","DOI":"10.1634\/theoncologist.5-6-445","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T21:38:39Z","timestamp":1093383519000},"page":"445-453","source":"Crossref","is-referenced-by-count":135,"title":["Childhood Cancers: Hepatoblastoma"],"prefix":"10.1093","volume":"5","author":[{"given":"Cynthia E.","family":"Herzog","sequence":"first","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, University of Texas-Houston Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Andrassy","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, University of Texas-Houston Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Eftekhari","sequence":"additional","affiliation":[{"name":"University of Texas M.D. Anderson Cancer Center, University of Texas-Houston Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,12,1]]},"reference":[{"key":"2021122210022817800_R1","first-page":"91","volume-title":"Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995","author":"Bulterys","year":"1999"},{"key":"2021122210022817800_R2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1200\/JCO.1991.9.12.2167","article-title":"Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children's Cancer Study Group","volume":"9","author":"Ortega","year":"1991","journal-title":"J Clin Oncol"},{"key":"2021122210022817800_R3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.1993.11.1.96","article-title":"Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group Study","volume":"11","author":"Douglass","year":"1993","journal-title":"J Clin Oncol"},{"key":"2021122210022817800_R4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","article-title":"Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/ continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group","volume":"18","author":"Ortega","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122210022817800_R5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/(SICI)1096-911X(199906)32:6<466::AID-MPO20>3.0.CO;2-1","article-title":"Congenital hepatoblastoma: a distinct entity?","volume":"32","author":"Ammann","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R6","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/S0959-8049(98)00281-0","article-title":"Survival and distribution pattern of childhood liver cancer in Taiwan","volume":"34","author":"Lee","year":"1998","journal-title":"Eur J Cancer"},{"key":"2021122210022817800_R7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-3476(98)70008-3","article-title":"Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry","volume":"132","author":"DeBaun","year":"1998","journal-title":"J Pediatr"},{"key":"2021122210022817800_R8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-3476(05)80297-5","article-title":"Risk of hepatoblastoma in familial adenomatous polyposis","volume":"119","author":"Giardiello","year":"1991","journal-title":"J Pediatr"},{"key":"2021122210022817800_R9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-3476(97)70239-7","article-title":"Association between hepatoblastoma and very low birth weight: a trend or a chance?","volume":"130","author":"Ikeda","year":"1997","journal-title":"J Pediatr"},{"key":"2021122210022817800_R10","first-page":"3032","article-title":"Increased risk of hepatoblastoma among immature children with a lower birth weight","volume":"58","author":"Tanimura","year":"1998","journal-title":"Cancer Res"},{"key":"2021122210022817800_R11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3476(98)70084-8","volume":"133","author":"Feusner","year":"1998","journal-title":"J Pediatr"},{"key":"2021122210022817800_R12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(98)70380-4","article-title":"Hepatoblastoma and birth weight","volume":"132","author":"Ribons","year":"1998","journal-title":"J Pediatr"},{"key":"2021122210022817800_R13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00043426-199611000-00070","article-title":"Frequent occurrence of prematurity among children with hepatoblastoma: a preliminary study","volume":"18","author":"Riley","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210022817800_R14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/00000478-199312000-00008","article-title":"Chemotherapy effects on hepatoblastoma. A histological study","volume":"17","author":"Saxena","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"2021122210022817800_R15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-3468(75)90095-0","article-title":"Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey-1974","volume":"10","author":"Exelby","year":"1975","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/1097-0142(19800115)45:2<315::AID-CNCR2820450219>3.0.CO;2-W","article-title":"Hepatoblastoma, thrombocytosis, and increased thrombopoietin","volume":"45","author":"Nickerson","year":"1980","journal-title":"Cancer"},{"key":"2021122210022817800_R17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/adc.69.1.171","article-title":"Extreme thrombocytosis as a diagnostic clue to hepatoblastoma","volume":"69","author":"Shafford","year":"1993","journal-title":"Arch Dis Child"},{"key":"2021122210022817800_R18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/stem.160329","article-title":"Thrombopoietin in patients with hepatoblastoma","volume":"16","author":"Komura","year":"1998","journal-title":"Stem Cells"},{"key":"2021122210022817800_R19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-3468(95)90762-9","article-title":"Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma\u2014A report from the German Cooperative Pediatric Liver Tumor Study HB-89","volume":"30","author":"Schweinitz","year":"1995","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.1997.15.3.1190","article-title":"Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group","volume":"15","author":"Tornout","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122210022817800_R21","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma\u2014results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"2021122210022817800_R22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00043426-199703000-00016","article-title":"Hepatoblastoma metastatic to brain: prolonged survival after multiple surgical resections of a solitary brain lesion","volume":"19","author":"Robertson","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210022817800_R23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1097-0142(19930201)71:3<859::AID-CNCR2820710333>3.0.CO;2-T","article-title":"Treatment of pulmonary metastases of initial stage 1 hepatoblastoma in childhood. Report from the Children's Cancer Group","volume":"71","author":"Feusner","year":"1993","journal-title":"Cancer"},{"key":"2021122210022817800_R24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mpo.2950240113","volume":"24","author":"Passmore","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3468(82)80508-3","article-title":"Alpha feto (aFP) monitoring of response to adriamycin in hepatoblastoma","volume":"17","author":"Pritchard","year":"1982","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1148\/radiology.164.1.3035605","article-title":"Hepatoblastoma: radiographic-pathologic correlation in 50 cases","volume":"164","author":"Dachman","year":"1987","journal-title":"Radiology"},{"key":"2021122210022817800_R27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2214\/ajr.158.1.1727341","article-title":"Hepatic masses in infants and children: CT evaluation","volume":"158","author":"Jabra","year":"1992","journal-title":"Am J Roentgenol"},{"key":"2021122210022817800_R28","first-page":"136","article-title":"Hepatoblastoma","volume":"11","author":"Stocker","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"2021122210022817800_R29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G","article-title":"Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma","volume":"64","author":"Haas","year":"1989","journal-title":"Cancer"},{"key":"2021122210022817800_R30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-911X(200003)34:3<165::AID-MPO1>3.0.CO;2-T","article-title":"Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study","volume":"34","author":"Parada","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-4608(97)00432-9","article-title":"Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study","volume":"104","author":"Sainati","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122210022817800_R32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0165-4608(93)90038-N","article-title":"Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenoma","volume":"67","author":"Griffin","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122210022817800_R33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<291::AID-GCC13>3.0.CO;2-J","article-title":"The first recurring chromosome translocation in hepatoblastoma: der (4)t(1;4) (q12;q34)","volume":"19","author":"Schneider","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"2021122210022817800_R34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(99)00203-4","article-title":"Cytogenetic characterization of childhood hepatoblastoma","volume":"119","author":"Ma","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"2021122210022817800_R35","first-page":"5007","article-title":"Biallelic inactivation of the APC gene in hepatoblastoma","volume":"55","author":"Kurahashi","year":"1995","journal-title":"Cancer Res"},{"key":"2021122210022817800_R36","first-page":"3320","article-title":"Somatic mutations of the APC gene in sporadic hepatoblastomas","volume":"56","author":"Oda","year":"1996","journal-title":"Cancer Res"},{"key":"2021122210022817800_R37","first-page":"269","article-title":"Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the \u03b2-catenin gene","volume":"59","author":"Koch","year":"1999","journal-title":"Cancer Res"},{"key":"2021122210022817800_R38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.onc.1203356","article-title":"Activation of \u03b2-catenin in epithelial and mesenchymal hepatoblastomas","volume":"19","author":"Wei","year":"2000","journal-title":"Oncogene"},{"key":"2021122210022817800_R39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3835(99)00433-4","article-title":"Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma","volume":"152","author":"Jeng","year":"2000","journal-title":"Cancer Lett"},{"key":"2021122210022817800_R40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1054\/bjoc.1999.0992","article-title":"H19 and IGF-2 allele-specific expression in hepatoblastoma","volume":"82","author":"Ross","year":"2000","journal-title":"Br J Cancer"},{"key":"2021122210022817800_R41","first-page":"213","volume-title":"Pediatric Surgical Oncology","author":"Bleacher","year":"1997"},{"key":"2021122210022817800_R42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","article-title":"Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology","volume":"33","author":"Schweinitz","year":"1997","journal-title":"Eur J Cancer"},{"key":"2021122210022817800_R43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1043805","article-title":"Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB89 and HB94","volume":"211","author":"Fuchs","year":"1999","journal-title":"Klin Padiatr"},{"key":"2021122210022817800_R44","first-page":"361","article-title":"The proposed Japanese TNM classification of primary liver carcinoma in infants and children","volume":"13","author":"Morita","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"2021122210022817800_R45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/bjs.1800820334","article-title":"Improved outcome for children with hepatoblastoma","volume":"82","author":"Stringer","year":"1995","journal-title":"Br J Surg"},{"key":"2021122210022817800_R46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3468(80)80765-2","article-title":"Preoperative chemotherapy for hepatoblastoma in children: report of six cases","volume":"15","author":"Andrassy","year":"1980","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-3468(89)80294-5","article-title":"Preoperative chemotherapy in \u201cunresectable\u201d hepatoblastoma","volume":"24","author":"Pierro","year":"1989","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0039-6060(98)70161-8","article-title":"Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and Adriamycin","volume":"123","author":"Seo","year":"1998","journal-title":"Surgery"},{"key":"2021122210022817800_R49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<136::AID-MPO12>3.0.CO;2-A","article-title":"Liver transplantation for malignant liver tumors in children","volume":"34","author":"Dower","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3476(00)44469-0","article-title":"Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence","volume":"136","author":"Reyes","year":"2000","journal-title":"J Pediatr"},{"key":"2021122210022817800_R51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3468(96)90147-5","article-title":"Results of liver transplantation in children with unresectable liver tumors","volume":"31","author":"Superina","year":"1996","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R52","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0022-3468(91)90678-M","article-title":"Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors","volume":"26","author":"Black","year":"1991","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R53","first-page":"259","article-title":"Adriamycin (NSC-123127) in pediatric malignancies","volume":"6","author":"Tan","year":"1975","journal-title":"Cancer Chemother Rep 3"},{"key":"2021122210022817800_R54","first-page":"173","article-title":"Cis-platin: an effective therapy for unresectable or recurrent hepatoblastoma","volume":"1","author":"Champion","year":"1982","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2021122210022817800_R55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/mpo.2950190310","article-title":"Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP Pilot Study","volume":"19","author":"Ninane","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<209::AID-MPO8>3.0.CO;2-0","article-title":"Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma","volume":"32","author":"Fuchs","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R57","first-page":"2170a","article-title":"Taxol in pediatric solid tumors: a Pediatric Oncology Group (POG) phase II study","volume":"18","author":"Harris","year":"1999","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"2021122210022817800_R58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-199807000-00006","article-title":"Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II trial","volume":"20","author":"Nitschke","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210022817800_R59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1701283","article-title":"Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors","volume":"22","author":"Hara","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2021122210022817800_R60","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/1097-0142(19950615)75:12<2966::AID-CNCR2820751226>3.0.CO;2-W","article-title":"Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors","volume":"75","author":"Hoff","year":"1995","journal-title":"Cancer"},{"key":"2021122210022817800_R61","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0022-3468(98)90282-2","article-title":"Transcatheter arterial chemoembolization in the treatment of hepatoblastoma","volume":"33","author":"Oue","year":"2000","journal-title":"J Pediatr Surg"},{"key":"2021122210022817800_R62","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1200\/JCO.2000.18.6.1279","article-title":"Feasibility and toxicity of chemoembolization for children with liver tumors","volume":"18","author":"Malogolowkin","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122210022817800_R63","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mpo.2950170528","article-title":"Intrahepatic arterial injections of cisplatin-phosphatidylcholine-Lipiodol suspension in two unresectable hepatoblastoma cases","volume":"17","author":"Sue","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"2021122210022817800_R64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1051-0443(99)70231-9","article-title":"Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma","volume":"10","author":"Han","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"2021122210022817800_R65","first-page":"S67","article-title":"An approach to handling pediatric liver tumors","volume":"109","author":"Stocker","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"2021122210022817800_R66","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/ajr.158.5.1566658","article-title":"Hepatic neoplasms: surgically relevant segmental anatomy and imaging techniques","volume":"158","author":"Gazelle","year":"1992","journal-title":"Am J Roentgenol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.5-6-445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.5-6-445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/5\/6\/445\/41837477\/oncolo_5_6_445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/5\/6\/445\/41837477\/oncolo_5_6_445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:05:47Z","timestamp":1640196347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/5\/6\/445\/6385865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,12,1]]},"published-print":{"date-parts":[[2000,12,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.5-6-445","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,12,1]]},"published":{"date-parts":[[2000,12,1]]}}}